RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Grand Pharmaceutical Group Stock

Grand Pharmaceutical Group Market capitalization 2024

Grand Pharmaceutical Group Market capitalization

15.96 B HKD

Ticker

512.HK

ISIN

BMG210A71016

WKN

A0Q8LD

In 2024, Grand Pharmaceutical Group's market cap stood at 15.96 B HKD, a 5.96% increase from the 15.06 B HKD market cap in the previous year.

The Grand Pharmaceutical Group Market capitalization history

YEARMarket Capitalization (undefined HKD)
202315.66
202216.55
202123.15
202020.4
201914.85
201813.71
20175.75
20163.55
2015119.21
2014-
2013-
2012-
2011-
2010-
2009-
2008-
2007-
2006-
2005-
2004-

Grand Pharmaceutical Group Aktienanalyse

What does Grand Pharmaceutical Group do?

China Grand Pharmaceutical and Healthcare Holdings Ltd is an innovative company in the healthcare and pharmaceutical industry in China. The company was founded in 1997 and is headquartered in Wuhan, Hubei Province. China Grand Pharma specializes in developing, manufacturing, and distributing high-quality medications, medical devices, and services. The company has multiple subsidiaries involved in various areas of the healthcare and pharmaceutical industry. China Grand Pharma’s main business areas include the production and sale of synthetic drugs, traditional Chinese medicines, biopharmaceuticals, veterinary medicine, and medical devices and equipment. The company has a high level of technological expertise in synthetic drug development and has a team of experienced scientists and researchers. China Grand Pharma has continuously invested in research and development to develop innovative and effective medications that meet the needs of patients in China and worldwide. The traditional Chinese medicine segment is another important area of China Grand Pharma’s business. The company holds a leading position in the market and offers a wide range of products made from natural plant extracts and traditional Chinese medicines. Biopharmaceuticals, based on innovative technologies such as recombinant DNA technology or stem cell research, are another important focus of China Grand Pharma. The company is able to develop and manufacture high-quality biopharmaceuticals that can be used for the prevention and treatment of serious diseases. China Grand Pharma is also a major player in the veterinary medicine market and offers a wide range of products for the health of livestock and pets. The company has a high level of technological expertise and has an extensive portfolio of products for the diagnosis, prevention, and treatment of animal diseases. The company also offers a wide range of medical devices and equipment for healthcare in hospitals and clinics. China Grand Pharma provides a variety of products, from diagnostic instruments to surgical tools. Overall, China Grand Pharmaceutical and Healthcare Holdings Ltd is one of the leading companies in the healthcare and pharmaceutical industry in China. The company has a comprehensive range of products and is able to provide high-quality products and services for a variety of applications and needs. China Grand Pharma is highly committed to researching and developing medications and technologies that can improve healthcare in China and enhance the lives of patients worldwide. The company has a strong presence in the Chinese market and has a well-established distribution infrastructure that allows it to distribute its products and services in China and beyond. Grand Pharmaceutical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Grand Pharmaceutical Group's Market Capitalization

Grand Pharmaceutical Group's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Grand Pharmaceutical Group's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Grand Pharmaceutical Group's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Grand Pharmaceutical Group’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Grand Pharmaceutical Group stock

What is the current Grand Pharmaceutical Group market capitalization?

The current market capitalization of Grand Pharmaceutical Group is 15.96 B HKD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Grand Pharmaceutical Group.

How has the market capitalization of Grand Pharmaceutical Group developed in recent years?

The market capitalization of Grand Pharmaceutical Group has increased/decreased by 5.96% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Grand Pharmaceutical Group?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Grand Pharmaceutical Group?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Grand Pharmaceutical Group have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Grand Pharmaceutical Group pay?

Over the past 12 months, Grand Pharmaceutical Group paid a dividend of 0.14 HKD . This corresponds to a dividend yield of about 3.08 %. For the coming 12 months, Grand Pharmaceutical Group is expected to pay a dividend of 0.16 HKD.

What is the dividend yield of Grand Pharmaceutical Group?

The current dividend yield of Grand Pharmaceutical Group is 3.08 %.

When does Grand Pharmaceutical Group pay dividends?

Grand Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Grand Pharmaceutical Group?

Grand Pharmaceutical Group paid dividends every year for the past 8 years.

What is the dividend of Grand Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.16 HKD are expected. This corresponds to a dividend yield of 3.45 %.

In which sector is Grand Pharmaceutical Group located?

Grand Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Grand Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Grand Pharmaceutical Group from 6/27/2024 amounting to 0.26 HKD, you needed to have the stock in your portfolio before the ex-date on 6/6/2024.

When did Grand Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Grand Pharmaceutical Group in the year 2023?

In the year 2023, Grand Pharmaceutical Group distributed 0.11 HKD as dividends.

In which currency does Grand Pharmaceutical Group pay out the dividend?

The dividends of Grand Pharmaceutical Group are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Grand Pharmaceutical Group

Our stock analysis for Grand Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Grand Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.